Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
for
Type 2 Diabetes
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT07032844
Recruiting
Effect of Preoperative Mobility Device Training on Postoperative Fall Incidence
for
Injury; Muscle, Ankle, and Foot, Multiple
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT03857945
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Location: Birmingham AL, Marietta GA, Atlanta GA, Nashville TN,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Birmingham AL, Montgomery AL, Atlanta GA, Nashville TN,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
for
Refractory Angina, Coronary Artery Disease
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Durham NC,
Sponsor: XyloCor Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07048808
Phase 2, Recruiting
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
for
HIV
Location: Birmingham AL, Atlanta GA, Boston MA, Seattle WA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT07569029
Phase 1, Recruiting
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
for
HIV
Location: Birmingham AL, Atlanta GA, Nashville TN, Houston TX,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT07390955
Phase 1, Recruiting
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
for
Psoriasis
Location: Birmingham AL, San Antonio TX, Chula Vista CA
Sponsor: InventisBio Co., Ltd
Sex: All
Age: 18 - 70
Code: NCT07489885
Phase 2, Recruiting
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
for
Cervical Cancer
Location: Birmingham AL, Centreville AL
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 21 - 65
Code: NCT04093388
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
for
Multiple Sclerosis
Location: Birmingham AL, Atlanta GA, Cordova TN, Savannah GA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18 - 65
Code: NCT07609719
Phase 4, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Birmingham AL, Knoxville TN, St Louis MO, Cincinnati OH,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase 2, Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Birmingham AL, Cullman AL, Atlanta GA, Knoxville TN,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Birmingham AL, Macon GA, North Little Rock AR,